Product Images Flovent Hfa

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 15 images provide visual information about the product associated with Flovent Hfa NDC 50090-0910 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

fluticasone propionate chemical structure - floventhfa spl graphic 01

fluticasone propionate chemical structure - floventhfa spl graphic 01

Figure 1. A 12-Week Clinical Trial in Subjects Aged 12 Years and Older Inadequately Controlled on Bronchodilators Alone: Mean Percent Change from Baseline in FEV1 Prior to AM Dose (Trial 1) - floventhfa spl graphic 02

Figure 1. A 12-Week Clinical Trial in Subjects Aged 12 Years and Older Inadequately Controlled on Bronchodilators Alone: Mean Percent Change from Baseline in FEV1 Prior to AM Dose (Trial 1) - floventhfa spl graphic 02

Figure 2. A 12-Week Clinical Trial in Subjects Aged 12 Years and Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change from Baseline in FEV1 Prior to AM Dose (Trial 2) - floventhfa spl graphic 03

Figure 2. A 12-Week Clinical Trial in Subjects Aged 12 Years and Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change from Baseline in FEV1 Prior to AM Dose (Trial 2) - floventhfa spl graphic 03

This text provides information about a study evaluating the change in FEV (Forced Expiratory Volume) from baseline. It mentions different treatments, including a placebo and various doses of FLOVENT HFA. Unfortunately, there is not enough information to determine the specific findings or conclusions of the study.*

Figure 3. A 16-Week Clinical Trial in Subjects Aged 12 Years and Older Requiring Chronic Oral Prednisone Therapy: Change in Maintenance Prednisone Dose - floventhfa spl graphic 04

Figure 3. A 16-Week Clinical Trial in Subjects Aged 12 Years and Older Requiring Chronic Oral Prednisone Therapy: Change in Maintenance Prednisone Dose - floventhfa spl graphic 04

This text appears to show a chart or table with percentage values indicating the subjects' response to different doses of a medication. The chart includes different dosage levels and the corresponding percentage of subjects exhibiting a reduction in dose. The medication being evaluated is likely called "FLOVENT HFA" and comes in two different strengths: 440 mcg and 880 mcg, to be taken twice daily. Unfortunately, without further context or interpretation of the chart, it is challenging to provide a more specific description of what these percentages represent.*

Figure A - floventhfa spl graphic 05

Figure A - floventhfa spl graphic 05

Figure B - floventhfa spl graphic 06

Figure B - floventhfa spl graphic 06

Fgure C - floventhfa spl graphic 07

Fgure C - floventhfa spl graphic 07

Figure D - floventhfa spl graphic 08

Figure D - floventhfa spl graphic 08

Figure E - floventhfa spl graphic 09

Figure E - floventhfa spl graphic 09

Figure F - floventhfa spl graphic 10

Figure F - floventhfa spl graphic 10

Figure G - floventhfa spl graphic 11

Figure G - floventhfa spl graphic 11

Figure H - floventhfa spl graphic 12

Figure H - floventhfa spl graphic 12

Figure I - floventhfa spl graphic 13

Figure I - floventhfa spl graphic 13

floventhfa spl graphic 14

floventhfa spl graphic 14

Label Image - lbl500900910

Label Image - lbl500900910

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.